| 43.53 Delayed Data As of Nov 20 |  -0.65 / -1.47%Today’s Change | 33.20 Today|||52-Week Range 45.81 | +20.18% Year-to-Date |
| Previous close | 44.18 |
| Today’s open | 44.01 |
| Day’s range | 43.40 - 44.39 |
| Volume | 21,791,753 |
| Average volume (3 months) | 21,743,109 |
| Market cap | $252.5B |
| Earnings growth (last year) | +202.42% |
| Earnings growth (this year) | +13.46% |
| Earnings growth (next 5 years) | +6.22% |
| Revenue growth (last year) | -0.53% |
| P/E ratio | 11.0 |
| Price/Sales | 4.18 |
| Price/Book | 3.65 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | -1.36 | -1.54% |
| MRKMerck | -1.57 | -2.06% |
| ABBVAbbVie | -1.39 | -1.55% |
| ABTAbbott Laboratories | -1.48 | -2.10% |
| Next reporting date | January 29, 2019 |
| EPS forecast (this quarter) | $0.65 |
| Annual revenue (last year) | $52.5B |
| Annual profit (last year) | $21.3B |
| Net profit margin | 40.55% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Ian C. Read |
Chief Operating Officer & Director Albert Bourla |
Corporate headquarters New York, New York |
